What are the recommended treatments for muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Muscle Spasms

For muscle spasms, first-line treatments include cyclobenzaprine for acute musculoskeletal conditions, baclofen for severe spasticity, and benzodiazepines when anxiety and muscle spasm coexist. 1

First-Line Pharmacological Options

  • Cyclobenzaprine (10-30 mg/day) is recommended as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions, but only for short periods (up to 2-3 weeks) 1, 2
  • Baclofen (starting at 10 mg/day with weekly increases up to 30 mg/day) is effective as a second-line drug for muscle spasm, particularly in patients with severe spasticity resulting from central nervous system injury or for muscle cramps associated with cirrhosis 3, 1
  • Benzodiazepines such as diazepam may be justified for management of muscle spasm, especially in situations where anxiety, muscle spasm, and pain coexist 3, 4
  • Tizanidine has shown efficacy for acute low back pain and can be considered as an alternative first-line agent, especially for chronic conditions with spasticity 3, 1

Medication Considerations and Cautions

  • Cyclobenzaprine is structurally similar to tricyclic antidepressants with similar potential adverse effects including sedation and anticholinergic effects 3, 2
  • Carisoprodol should be avoided due to concerns about drug abuse potential and has been removed from the European market 3, 1
  • Muscle relaxants should generally be avoided in elderly patients due to increased risk of falls, sedation, and anticholinergic effects 3, 1
  • Benzodiazepines are associated with a higher total number of adverse events (particularly drowsiness and dizziness) compared with placebo 3, 5
  • Never abruptly discontinue muscle relaxants after prolonged use; implement a slow tapering period to prevent withdrawal symptoms, particularly with baclofen 3, 1

Specific Clinical Scenarios

  • For muscle spasms associated with cirrhosis: baclofen (10 mg/day, with weekly increases up to 30 mg/day) or albumin infusion are recommended 3, 1
  • For acute low back pain with muscle spasm: skeletal muscle relaxants have been found moderately superior to placebo for short-term pain relief 3
  • For neuropathic pain with muscle spasm: gabapentin or topiramate may provide benefit 3
  • For pyridoxine deficiency-related muscle spasms (rare): pyridoxine supplementation should be considered, particularly in patients with diabetes 6

Non-Pharmacological Approaches

  • Rest and activity modification are recommended for acute muscle spasms 1
  • Stretching, massaging the affected muscles, and application of ice should accompany drug therapy 1
  • Rhythmic movement strategies can help normalize muscle activity for functional tremors or spasms 1
  • Postural alignment training can help normalize movement patterns and muscle activity 1

Monitoring and Follow-up

  • During treatment with muscle relaxants, patients should be monitored for adverse effects, particularly central nervous system effects such as drowsiness, dizziness, and cognitive impairment 3, 5
  • For patients with neuromuscular disease requiring muscle relaxants, monitoring of neuromuscular blockade is recommended 3
  • Assess effectiveness of treatment regularly and discontinue if no benefit is observed after a reasonable trial period 1

Important Caveats

  • Evidence for long-term use of muscle relaxants is limited, and they should generally be used for short durations 3, 4
  • Benzodiazepines have not shown definitive evidence of direct analgesic properties in most clinical circumstances 7
  • Muscle relaxants may be ineffective for certain types of muscle spasms, such as those related to specific vitamin deficiencies 6
  • Combination therapy with multiple agents should be approached cautiously due to increased risk of adverse effects 1

References

Guideline

Treatment of Muscle Spasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews, 2012

Research

The benzodiazepines as adjuvant analgesics.

Journal of pain and symptom management, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.